↓ Skip to main content

Dove Medical Press

Article Metrics

The benefits and risks of testosterone replacement therapy: a review

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2009
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#9 of 1,219)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
12 news outlets
twitter
9 tweeters
patent
3 patents
facebook
5 Facebook pages
wikipedia
9 Wikipedia pages
googleplus
1 Google+ user
video
5 video uploaders

Citations

dimensions_citation
242 Dimensions

Readers on

mendeley
272 Mendeley
citeulike
1 CiteULike
Title
The benefits and risks of testosterone replacement therapy: a review
Published in
Therapeutics and Clinical Risk Management, June 2009
DOI 10.2147/tcrm.s3025
Pubmed ID
Authors

John Morley

Abstract

Increased longevity and population aging will increase the number of men with late onset hypogonadism. It is a common condition, but often underdiagnosed and undertreated. The indication of testosterone-replacement therapy (TRT) treatment requires the presence of low testosterone level, and symptoms and signs of hypogonadism. Although controversy remains regarding indications for testosterone supplementation in aging men due to lack of large-scale, long-term studies assessing the benefits and risks of testosterone-replacement therapy in men, reports indicate that TRT may produce a wide range of benefits for men with hypogonadism that include improvement in libido and sexual function, bone density, muscle mass, body composition, mood, erythropoiesis, cognition, quality of life and cardiovascular disease. Perhaps the most controversial area is the issue of risk, especially possible stimulation of prostate cancer by testosterone, even though no evidence to support this risk exists. Other possible risks include worsening symptoms of benign prostatic hypertrophy, liver toxicity, hyperviscosity, erythrocytosis, worsening untreated sleep apnea or severe heart failure. Despite this controversy, testosterone supplementation in the United States has increased substantially over the past several years. The physician should discuss with the patient the potential benefits and risks of TRT. The purpose of this review is to discuss what is known and not known regarding the benefits and risks of TRT.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 272 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
Italy 1 <1%
Canada 1 <1%
United States 1 <1%
Philippines 1 <1%
Unknown 267 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 46 17%
Student > Master 39 14%
Researcher 36 13%
Student > Ph. D. Student 27 10%
Other 24 9%
Other 60 22%
Unknown 40 15%
Readers by discipline Count As %
Medicine and Dentistry 107 39%
Biochemistry, Genetics and Molecular Biology 25 9%
Agricultural and Biological Sciences 20 7%
Sports and Recreations 13 5%
Psychology 8 3%
Other 50 18%
Unknown 49 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 117. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2022.
All research outputs
#265,859
of 21,360,625 outputs
Outputs from Therapeutics and Clinical Risk Management
#9
of 1,219 outputs
Outputs of similar age
#1,691
of 170,225 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 11 outputs
Altmetric has tracked 21,360,625 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,219 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,225 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.